Significant Association Between XRCC1 Expression and Its Rs25487 Polymorphism and Radiotherapy-Related Cancer Prognosis

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Jun 7

PMID 34094945

Citations 6

Authors

Li Gong

Ming Luo

Renhuang Sun

Li Qiu

Chunli Chen

Zhiguo Luo

Affiliations

Soon will be listed here.

Abstract

Background/aims: XRCC1 (X-ray repair cross-complementing protein 1) expression and its single nucleotide polymorphism XRCC1 rs25487 (G>A) may be related to radiotherapy-related cancer prognosis or radiation-induced side effects. However, this association is controversial. We performed a bioinformatic analysis and a meta-analysis to obtain comprehensive results. TCGA data sets and eligible publications published before November 31, 2020 were retrieved by searching the PubMed, Web of Science and CNKI (China National Knowledge Infrastructure) databases. ORs (odds ratios) and HRs (hazard ratios) with their corresponding 95% CIs (confidence intervals) were calculated to evaluate associations. For XRCC1 single nucleotide polymorphisms, we employed three types of comparisons: GA vs GG, AA vs GG and GA+AA vs GG.

Results: Sixty nine articles with 10232 patients and 17 TCGA data sets with 2705 patients were included in the analysis. We observed that high XRCC1 expression was associated with an increased risk of minor treatment response and poor overall survival, XRCC1 rs25487 was associated with reduced risk of minor treatment response in esophageal cancer and an increased risk of high-grade side effects in head and neck cancer.

Conclusion: The results suggest that XRCC1 expression and rs25487 polymorphism are prognostic factors for patients receiving radiotherapy-related treatment. Considering the insufficient treatment parameters provided and the various sample sizes in most of the studies, we suggest that genetic association studies related to radiation-based treatment should include more cancer types with sufficient statistical power and more detailed clinical parameters.

Citing Articles

CRISPR/Cas9 system: a novel approach to overcome chemotherapy and radiotherapy resistance in cancer.

Noruzi S, Mohammadi R, Jamialahmadi K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39560750 DOI: 10.1007/s00210-024-03480-2.

Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.

Deasy J Semin Radiat Oncol. 2024; 34(4):379-394.

PMID: 39271273 PMC: 11698470. DOI: 10.1016/j.semradonc.2024.07.012.

Association between polymorphism with prognosis of head and neck squamous cell carcinomas: A meta-analysis.

Najafi-Ghobadi K, Rajabi-Moghaddam M, Abbaszadeh H Heliyon. 2023; 9(10):e21111.

PMID: 37916104 PMC: 10616328. DOI: 10.1016/j.heliyon.2023.e21111.

Association between single nucleotide polymorphisms in DNA repair genes and the efficacy of radiotherapy in nasopharyngeal carcinoma patients.

Benzeid R, Gihbid A, Tawfik N, Benchakroun N, Bendahhou K, Benider A Contemp Oncol (Pozn). 2023; 27(1):28-34.

PMID: 37266339 PMC: 10230242. DOI: 10.5114/wo.2023.127307.

Biological Mechanisms to Reduce Radioresistance and Increase the Efficacy of Radiotherapy: State of the Art.

Busato F, El Khouzai B, Mognato M Int J Mol Sci. 2022; 23(18).

PMID: 36142122 PMC: 9499172. DOI: 10.3390/ijms231810211.

References

Terrazzino S, La Mattina P, Gambaro G, Masini L, Franco P, Canonico P . Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients. Int J Radiat Oncol Biol Phys. 2011; 83(2):504-11. DOI: 10.1016/j.ijrobp.2011.06.2012. View

Ishikawa A, Suga T, Shoji Y, Kato S, Ohno T, Ishikawa H . Genetic variants of NPAT-ATM and AURKA are associated with an early adverse reaction in the gastrointestinal tract of patients with cervical cancer treated with pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 81(4):1144-52. DOI: 10.1016/j.ijrobp.2010.09.012. View

Falvo E, Strigari L, Citro G, Giordano C, Boboc G, Fabretti F . SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. J Exp Clin Cancer Res. 2012; 31:7. PMC: 3285050. DOI: 10.1186/1756-9966-31-7. View

Zhai X, Hu Q, Gu K, Wang J, Zhang J, Wu Y . Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy. Asia Pac J Clin Oncol. 2013; 12(1):e125-32. DOI: 10.1111/ajco.12117. View

Wong H, Kim D, Hogue B, McNeill D, Wilson 3rd D . DNA damage levels and biochemical repair capacities associated with XRCC1 deficiency. Biochemistry. 2005; 44(43):14335-43. DOI: 10.1021/bi051161o. View

Paez D, Salazar J, Pare L, Pertriz L, Targarona E, del Rio E . Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. Int J Radiat Oncol Biol Phys. 2011; 81(5):1319-27. DOI: 10.1016/j.ijrobp.2011.01.025. View

Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L . Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol. 2011; 99(3):356-61. DOI: 10.1016/j.radonc.2011.05.062. View

Petermann E, Keil C, Oei S . Roles of DNA ligase III and XRCC1 in regulating the switch between short patch and long patch BER. DNA Repair (Amst). 2006; 5(5):544-55. DOI: 10.1016/j.dnarep.2005.12.008. View

Smith J, Wasserman I, Milgrom S, Chow O, Chen C, Patil S . Single Nucleotide Polymorphism TGFβ1 R25P Correlates with Acute Toxicity during Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients. Int J Radiat Oncol Biol Phys. 2017; 97(5):924-930. PMC: 5389377. DOI: 10.1016/j.ijrobp.2016.12.015. View

10.

Andreassen C, Alsner J . Genetic variants and normal tissue toxicity after radiotherapy: a systematic review. Radiother Oncol. 2009; 92(3):299-309. DOI: 10.1016/j.radonc.2009.06.015. View

11.

Wang J, Guo C, Gong X, Ao F, Huang Y, Huang L . The impacts of genetic polymorphisms in genes of base excision repair pathway on the efficacy and acute toxicities of (chemo)radiotherapy in patients with nasopharyngeal carcinoma. Oncotarget. 2017; 8(45):78633-78641. PMC: 5667987. DOI: 10.18632/oncotarget.20203. View

12.

Alsbeih G, Al-Harbi N, Al-Hadyan K, El-Sebaie M, Al-Rajhi N . Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes. Radiat Res. 2010; 173(4):505-11. DOI: 10.1667/RR1769.1. View

13.

Li H, You Y, Lin C, Zheng M, Hong C, Chen J . XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients. Radiat Oncol. 2013; 8:31. PMC: 3570437. DOI: 10.1186/1748-717X-8-31. View

14.

Alsbeih G, El-Sebaie M, Al-Rajhi N, Al-Harbi N, Al-Hadyan K, Al-Buhairi M . Association between XRCC1 G399A Polymorphism and Late Complications to Radiotherapy in Saudi Head and Neck Cancer Patients. J Egypt Natl Canc Inst. 2010; 20(3):302-8. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

16.

Zschenker O, Raabe A, Boeckelmann I, Borstelmann S, Szymczak S, Wellek S . Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol. 2010; 97(1):26-32. DOI: 10.1016/j.radonc.2010.01.016. View

17.

Mahjabeen I, Ali K, Zhou X, Kayani M . Deregulation of base excision repair gene expression and enhanced proliferation in head and neck squamous cell carcinoma. Tumour Biol. 2014; 35(6):5971-83. DOI: 10.1007/s13277-014-1792-5. View

18.

Venkatesh G, Manjunath V, Mumbrekar K, Negi H, Fernandes D, Sharan K . Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients. PLoS One. 2014; 9(3):e89079. PMC: 3942321. DOI: 10.1371/journal.pone.0089079. View

19.

Langsenlehner T, Renner W, Gerger A, Hofmann G, Thurner E, Kapp K . Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol. 2011; 98(3):387-93. DOI: 10.1016/j.radonc.2011.01.021. View

20.

Chang-Claude J, Popanda O, Tan X, Kropp S, Helmbold I, von Fournier D . Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005; 11(13):4802-9. DOI: 10.1158/1078-0432.CCR-04-2657. View